Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis

Diffuse large B-cell lymphoma (DLBCL) represents 30-40% of all non-Hodgkin lymphomas (NHL) and is a disease with an aggressive behavior. Because about one-third of DLBCL patients will be refractory or resistant to standard therapy, several studies focused on identification of new individual prognost...

Descripción completa

Detalles Bibliográficos
Autores principales: Cioroianu, Alexandra Ioana, Stinga, Patricia Irina, Sticlaru, Liana, Cioplea, Mirela Daniela, Nichita, Luciana, Popp, Cristiana, Staniceanu, Florica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942707/
https://www.ncbi.nlm.nih.gov/pubmed/31934533
http://dx.doi.org/10.1155/2019/8586354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942707/
https://www.ncbi.nlm.nih.gov/pubmed/31934533
http://dx.doi.org/10.1155/2019/8586354

Ejemplares similares